Who owns SAB BIOTHERAPEUTICS INC?
- Ticker: SABSW
- CUSIP Number: 78397t111
Tip: Access positions for across all investors
Analyze quarterly positions in Sab Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sab Biotherapeutics stock
Who bought or sold SAB BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| LMR Partners | 540k | $13k | 0% | Sep 2025 |
|
| Morgan Stanley | 146k | $4.9k | 100% | Jun 2025 |
|
| Clear Street | 79k | $2.6k | 100% | Jun 2025 |
|
| Millennium Management | 63k | $1.5k | 0% | Sep 2025 |
|
| Susquehanna International | 26k | $749.607000 | 100% | Sep 2025 |
|
| UBS Group | 23k | $538.522000 | 100% | Sep 2025 |
|
| Walleye Trading | 11k | $267.602400 | -64% | Sep 2025 |
|
| Wolverine Asset Management | 1.8k | $42.015200 | -61% | Sep 2025 |
|
| Goss Wealth Management | 1.1k | $24.977600 | 0% | Sep 2025 |
|
| Toronto-Dominion Bank | 200.00 | $5.000000 | 100% | Sep 2025 |
|